GlassScriptPhysician profile
Sheryl Jawetz
NPI 1265497267
$1,135.58
in general payments reported to CMS, 2019-2025
18 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2021: $65.58 · 2022: $237 · 2023: $129 · 2024: $280 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $260.58 | 2022-2025 | Bexsero |
| Merck Sharp & Dohme LLC | $141.18 | 2019-2024 | Gardasil 9, Vaxelis, Vaxneuvance |
| Galderma Laboratories, L.P. | $128.16 | 2019 | |
| Sanofi Pasteur INC. | $112.53 | 2021-2024 | |
| Novo Nordisk INC | $75.29 | 2019-2025 | Sogroya |
| Sanofi-Aventis U.S. LLC | $73.63 | 2024-2025 | |
| Ascendis Pharma Endocrinology INC | $68.34 | 2022-2024 | |
| Pfizer INC. | $66.54 | 2019 | |
| Tolmar, INC. | $47.11 | 2024-2025 | Fensolvi |
| Abbvie INC. | $27.46 | 2022-2025 | |
| Sobi, INC | $26.81 | 2021-2023 | |
| Azurity Pharmaceuticals, INC. | $17.33 | 2025 | Triptodur |
| Arbor Pharmaceuticals, INC. | $17.12 | 2019 | |
| Bavarian Nordic A/S | $17.11 | 2025 | Vivotif |
| Ars Pharmaceuticals Operations, INC. | $15.94 | 2025 | Neffy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $15.33 | 2019 | |
| Kaleo, INC. | $14.08 | 2022 | |
| Sandoz INC. | $11.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheryl Jawetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.